Magenta Therapeutics, Inc.·4

Feb 17, 5:17 PM ET

Olson Lisa 4

4 · Magenta Therapeutics, Inc. · Filed Feb 17, 2022

Insider Transaction Report

Form 4
Period: 2022-02-15
Olson Lisa
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-15+100,000100,000 total
    Exercise: $3.19Exp: 2032-02-14Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on the first quarter following the vesting commencement date. The vesting commencement date is February 1, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION